Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FR9UJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $174,348
Award facts
- Contract value 100% obligated
- $174,348.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order (Contract No. 4569420059) by the Defense Logistics Agency on September 11, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order carries a ceiling value of $174,348.16 and is scheduled for completion by September 12, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken facility. ENBREL (etanercept) is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, representing a critical pharmaceutical supply for military and federal healthcare beneficiaries.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of brand-name and generic medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare programs worldwide. The Defense Logistics Agency Troop Support is transitioning to the Pharmaceutical Prime Vendor Global Program Generation V contracts, which are expected to involve multiple regional awards across several contractors, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FR9UJ?
SPE2DB25FR9UJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FR9UJ worth?
The government has obligated $174,348 on SPE2DB25FR9UJ.
Is contract SPE2DB25FR9UJ an order under another contract?
Yes. SPE2DB25FR9UJ is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9UJ competed?
The extent of competition for SPE2DB25FR9UJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award